Pomdoctor Limited (POM)
NASDAQ: POM · Real-Time Price · USD
0.8290
+0.0283 (3.53%)
Sep 17, 2026, 4:00 PM EDT - Market closed
Pomdoctor Employees
Pomdoctor had 165 employees as of December 31, 2025. The number of employees increased by 9 or 5.77% compared to the previous year.
Employees
165
Change (1Y)
9
Growth (1Y)
5.77%
Revenue / Employee
$346,524
Profits / Employee
-$184,199
Market Cap
6.18M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 165 | 9 | 5.77% |
| Dec 31, 2024 | 156 | -4 | -2.50% |
| Dec 31, 2022 | 160 | -40 | -20.00% |
| Dec 31, 2020 | 200 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,200 |
| Merck & Co. | 75,000 |
| AbbVie | 57,000 |
| Eli Lilly and Company | 50,000 |
| cbdMD | 42 |
| NuCana | 12 |
| Processa Pharmaceuticals | 12 |
| Phaos Technology Holdings (Cayman) Limited | 10 |
POM News
- 7 days ago - POMDOCTOR LIMITED to Participate in H.C. Wainwright's 28th Annual Global Investment Conference - PRNewsWire
- 21 days ago - POMDOCTOR LIMITED Initiates U.S. Market Preparation and Unveils Expansion Strategy - PRNewsWire
- 5 weeks ago - POMDOCTOR LIMITED Highlights Healthcare Intelligence Flywheel as a Self-Reinforcing Growth Engine - PRNewsWire
- 6 weeks ago - POMDOCTOR LIMITED Highlights Four-Tier Diversified Revenue Structure - PRNewsWire
- 2 months ago - POMDOCTOR LIMITED Advances Healthcare Data Asset Strategy to Strengthen AI-Powered Chronic Disease Management Capabilities - PRNewsWire
- 2 months ago - PomDoctor regains Nasdaq compliance - TheFly
- 2 months ago - POMDOCTOR LIMITED Regains Compliance with Nasdaq Bid Price Requirement - PRNewsWire
- 2 months ago - PomDoctor continues efforts to advance chronic disease management ecosystem - TheFly